November 7, 2011
Takara Bio reported sales of ¥8,642 million (+2.4% over the corresponding period of the previous year) in its consolidated settlement of accounts for April-September 2011. Growth was driven by increased sales of research reagents in the mainstay genetic engineering research...read more